Q1 2020
Released May 7, 2020, before the open
10-Q filed May 7, 2020, 37 days after period end · 0001104659-20-057762
Q1 2020 · 10-Q
Revenue—
Net Income-$5.77M-$5.77M N/M vs Q1 2019N/M vs Q4 2019
EPS Diluted-$0.14-$0.14 N/M vs Q1 2019no prior Q4 2019 on file
Operating Income-$4,597,015N/M
Operating Cash Flow-$3,376,262N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | — | $0.00 | $428.03K | $0.00 |
| Net Income | -$5.77M | -$3.22M | -$2.72M | -$4.86M |
| EPS Diluted | -$0.14 | -$0.14 | -$0.13 | -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR